TherapeuticsMD, Inc.

NasdaqGS:TXMD Stock Report

Market Cap: US$19.1m

TherapeuticsMD Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TXMD Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Dec 25BuyUS$14,031Thomas ThompsonIndividual8,400US$1.67
14 Apr 25BuyUS$489Marlan WalkerIndividual490US$1.00
14 Apr 25BuyUS$326Thomas ThompsonIndividual325US$1.00
10 Apr 25BuyUS$1,994Marlan WalkerIndividual2,303US$0.87

Insider Trading Volume

Insider Buying: TXMD insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TXMD?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders187,6671.62%
Institutions1,476,55612.8%
Hedge Funds1,827,41315.8%
General Public8,082,72669.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 30.15% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.3%
Rubric Capital Management LP
1,192,191US$2.0m0%0.02%
5.49%
Clearline Capital LP
635,222US$1.0m0%0.08%
3.26%
The Vanguard Group, Inc.
376,828US$621.8k-0.57%no data
2.97%
Tejara Capital Limited
344,203US$567.9k-0.01%0.28%
1.81%
ADAR1 Capital Management, LLC
209,210US$345.2k0%0.03%
1.13%
Morgan Stanley
130,572US$215.4k-0.49%no data
1%
BlackRock, Inc.
116,132US$191.6k0%no data
0.94%
Geode Capital Management, LLC
109,083US$180.0k0%no data
0.64%
Marlan Walker
73,639US$121.5k-8.6%no data
0.52%
Cooper Collins
60,516US$99.9k0%no data
0.32%
Thomas Thompson
37,512US$61.9k28.9%no data
0.31%
Renaissance Technologies LLC
35,500US$58.6k138%no data
0.3%
Citadel Advisors LLC
34,273US$56.6k0%no data
0.29%
Bridgeway Capital Management, LLC
34,000US$56.1k0%no data
0.26%
State Street Global Advisors, Inc.
30,100US$49.7k0%no data
0.14%
Northern Trust Global Investments
16,457US$27.2k0%no data
0.12%
J. Goldman & Co., L.P.
13,562US$22.4k0%no data
0.1%
Two Sigma Securities, LLC
11,967US$19.7k14.7%no data
0.073%
Gail Naughton
8,500US$14.0k0%no data
0.072%
FMR LLC
8,289US$13.7k0%no data
0.065%
Joseph Ziegler
7,500US$12.4k0%no data
0.024%
Tower Research Capital Europe Limited
2,733US$4.5k-5.17%no data
0.0076%
Osaic Wealth, Inc.
877US$1.4k4.28%no data
0.0058%
National Bank Investments Inc.
670US$1.1k-5.63%no data
0.0031%
UBS Asset Management AG
362US$597.8-92%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/04 18:02
End of Day Share Price 2026/01/02 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

TherapeuticsMD, Inc. is covered by 17 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John TannerCantor Fitzgerald & Co.
Oren LivnatCitizens JMP Securities, LLC
Robert LabickCJS Securities, Inc.